Related Experiment Video
Updated: Aug 10, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 16, 2013
Human T-lymphotropic virus type I Tax protein utilizes distinct pathways for p53 inhibition that are cell
C A Pise-Masison1, R Mahieux, M Radonovich
1Basic Research Laboratory, Virus Tumor Biology Section, NCI, National Institutes of Health, Bethesda, Maryland 20892, USA.
Abstract:
p53 plays a pivotal role in transmitting signals from many forms of genotoxic stress to genes and factors that control the cell cycle and apoptosis. We have previously shown that the human T-lymphotropic virus type I Tax protein can inhibit p53 function. Recently we reported that Tax inhibits p53 function in Jurkat cells and mouse embryo fibroblasts through a mechanism involving the nuclear factor kappa B pathway and correlates with phosphorylation on serines 15 and 392 of p53. However, several groups have also observed a mechanism that correlates with p300 binding of Tax. To address this controversy and to determine the mechanism by which Tax inhibits p53 function, we examined the activation functions of Tax required for p53 inhibition. In HeLa and H1299 cells the cAMP-response element-binding protein/activating transcription factor activation function is essential, as demonstrated by the Tax mutants M47 and K88A. In addition, expression of exogenous p300 in H1299 cells allows full recovery of p53 transactivation in the presence of Tax. Consistent with p300 being a limiting factor in H1299, Saos-2, and HeLa cells, we found that the level of endogenous p300 is relatively low in these cells compared with Jurkat cells or the human T-lymphotropic virus type I-infected C81 and MT2 cells. Thus our data suggests that Tax utilizes distinct mechanisms to inhibit p53 function that are cell type-dependent.
Insights
The human T-lymphotropic virus type I Tax protein inhibits p53 function through cell-type-specific mechanisms. Tax
Area of Science:
- Molecular Biology
- Virology
- Cell Biology
Background:
- p53 is crucial for cellular response to genotoxic stress, regulating cell cycle and apoptosis.
- The human T-lymphotropic virus type I (HTLV-1) Tax protein is known to inhibit p53 function.
- Previous studies suggest conflicting mechanisms for Tax-mediated p53 inhibition, involving NF-kappaB and p300 binding.
Purpose of the Study:
- To elucidate the precise mechanisms by which HTLV-1 Tax inhibits p53.
- To investigate the role of Tax activation functions and co-factor availability in p53 inhibition.
- To resolve the controversy regarding the pathways utilized by Tax to suppress p53 activity.
Main Methods:
- Analysis of Tax mutants (M47, K88A) to assess essential activation functions for p53 inhibition.
- Examination of p53 transactivation recovery upon exogenous p300 expression in various cell lines.
- Quantification of endogenous p300 levels in different cell types, including HTLV-1 infected cells.
Main Results:
- The cAMP-response element-binding protein/activating transcription factor (CREB/ATF) activation function of Tax is essential for p53 inhibition in HeLa and H1299 cells.
- Overexpression of p300 restored p53 transactivation in Tax-expressing H1299 cells, indicating p300 acts as a limiting factor.
- Lower endogenous p300 levels were observed in H1299, Saos-2, and HeLa cells compared to Jurkat or HTLV-1 infected cells.
Conclusions:
- HTLV-1 Tax employs distinct, cell type-dependent mechanisms to inhibit p53 function.
- p300 availability is a critical determinant in the pathway of Tax-mediated p53 inhibition.
- Understanding these mechanisms is vital for comprehending HTLV-1 pathogenesis and developing therapeutic strategies.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly

